Elizabeth Alcamo

Private Equity Investor bei Versant Venture Management LLC

Health Technology

Finance

Consumer Services

Aktive Positionen von Elizabeth Alcamo

Unternehmen	Position	Beginn	Ende
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.	Private Equity Investor	01.10.2020	-

Unternehmen	Position	Beginn	Ende
CODA Biotherapeutics, Inc. CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01.06.2017	01.05.2019
4D MOLECULAR THERAPEUTICS, INC.	Corporate Officer/Principal	01.04.2016	01.06.2017
ADVERUM BIOTECHNOLOGIES, INC.	Corporate Officer/Principal	01.04.2014	01.04.2016

Williams College	Undergraduate Degree
Massachusetts Institute of Technology	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Private Equity Investor	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
4D MOLECULAR THERAPEUTICS, INC.	Health Technology
ADVERUM BIOTECHNOLOGIES, INC.	Health Technology

Private Unternehmen	2
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.	Finance
CODA Biotherapeutics, Inc. CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.	Health Technology

Private Unternehmen

Finance

Health Technology